Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.091 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |